FDA Drug Application (021861) for PATANASE by ALCON PHARMS LTD

Back to FDA Applications sponsored by ALCON PHARMS LTD

Application Number021861
Product Number001
FormSPRAY, METERED;NASAL
Dosage0.665MG/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePATANASE
Active IngredientOLOPATADINE HYDROCHLORIDE



Back to FDA Applications sponsored by ALCON PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.